- Approved Service Delivery Timelines for FY 2023-2024 and FY 2024-2025
- National Drug Authority Pharmacovigilance communication strategy
- The National Drug Policy and Authority (Fees) Regulations 2022
- National Medicines Policy
- Strategic and implementation action plan 2020/21 – 2024/25
- NDA Report to the nation FY 2020 – 2021
- Inspectorate and enforcement publication Vol 1 July – December 2020
- NDA Risk management Policy
- NDA Annual pharmacovigilance report 2019/2020
- Signed joint Communique
- Published EBATIC Paper sept 2017
- Veterinary Medicines Updates Bulletin Issue 5 June 2020
- Pharmacovigilance Bulletin June 2020
- Product applications with incomplete submission recommended for dismissal
Toll Free: 0800 101 999
National Drug Authority
Safe Drugs Save Lives
- Home
- About Us
- Downloads
- DIRECTORATES
- Directorate of Inspectorate & Enforcement Services
- Directorate of Product Assessment & Registration
- Directorate of Product Safety
- Directorate of Corporate Services
- Directorate of Laboratory Services
- Directorate of Human Resource & Administration
- Directorate of Veterinary Services
- Office of the Secretary to the Authority
- Public Relations Unit
- REGISTERS
- Contact Us
- Home
- About Us
- Downloads
- DIRECTORATES
- Directorate of Inspectorate & Enforcement Services
- Directorate of Product Assessment & Registration
- Directorate of Product Safety
- Directorate of Corporate Services
- Directorate of Laboratory Services
- Directorate of Human Resource & Administration
- Directorate of Veterinary Services
- Office of the Secretary to the Authority
- Public Relations Unit
- REGISTERS
- Contact Us
Publications
You are here:
- Home
- Publications
